Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

24.52
+0.26981.11%
Post-market: 23.58-0.9404-3.84%16:04 EDT
Volume:2K
Turnover:37.85K
Market Cap:5.64M
PE:- -
High:24.52
Open:24.22
Low:23.58
Close:24.25
52wk High:27.94
52wk Low:22.89
Shares:230.00K
Float Shares:230.00K
Volume Ratio:1.31
T/O Rate:0.68%
Dividend:0.41
Dividend Rate:1.68%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AlzeCure Pharma to Present at Redeye Neurology Day

Reuters
·
Oct 07

Deutsche Bank Keeps Their Sell Rating on Novo Nordisk (0QIU)

TIPRANKS
·
Oct 07

Novo Nordisk Probes Patient Priorities in German Hemophilia A Study

TIPRANKS
·
Oct 07

Lilly’s New Basal Insulin Candidate Clears Key Early Trial Milestone

TIPRANKS
·
Oct 07

General Medicine Raises $120 Mln to Build the Healthcare Store

Reuters
·
Oct 06

General Medicine - Series B Financing Led by Andreessen Horowitz (a16z), with Participation from Matrix, Vxi Capital, Eli Lilly and Company

THOMSON REUTERS
·
Oct 06

Viking Therapeutics, Inc.: Reporting Results from Part 2 of Vanquish-1 Study in 2027

THOMSON REUTERS
·
Oct 06

Viking Therapeutics Announces Initiation of Vk2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

THOMSON REUTERS
·
Oct 06

Scholar Rock Holding (SRRK) Dropped, What Is Driving Attention Now?

Simply Wall St.
·
Oct 06

Moderately bullish activity in Hims and Hers Health with shares up 3.07%

TIPRANKS
·
Oct 06

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

TIPRANKS
·
Oct 06

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%

TIPRANKS
·
Oct 06

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Oct 06

Lilly Expands Oncology Footprint with FDA Win for Pancreatic Cancer Drug

Dow Jones
·
Oct 05

Eli Lilly treatment of pancreatic cancer granted orphan designation

TIPRANKS
·
Oct 05

TRex Bio Files for Nasdaq IPO

MT Newswires Live
·
Oct 05

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

THOMSON REUTERS
·
Oct 05

J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Oct 05

Eli Lilly Presents New Ebglyss Data from Phase 3 ADorable-1 Pediatric Atopic Dermatitis Study at Fall Clinical 2026

Reuters
·
Oct 05

Novo Nordisk Could Raise Guidance Alongside Strong Results

Dow Jones
·
Oct 05